<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01204268</url>
  </required_header>
  <id_info>
    <org_study_id>APC-BRAIN-2009</org_study_id>
    <nct_id>NCT01204268</nct_id>
  </id_info>
  <brief_title>The Neuroprotection of Sevoflurane Preconditioning on Intracranial Aneurysm Surgery</brief_title>
  <official_title>The Neuroprotection of Sevoflurane Preconditioning on Perioperative Ischemia-reperfusion Injury During Intracranial Aneurysm Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study is designed to clarify the neuroprotective effect of sevoflurane
      preconditioning on the patients underwent intracranial aneurysm surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current study is designed to clarify the neuroprotective effect of sevoflurane
      preconditioning on the patients underwent intracranial aneurysm surgery. The patients with
      cerebral aneurysm will be recruited in current study. The sevoflurane preconditioning will be
      performed before the surgical procedure. The neurological injury biomarkers, such as S-100b
      and NSE will be detected. The neurological function and recovery will be assessed after the
      surgery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">October 2011</completion_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>S-100B,NSE</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Karnofsky Performance Scale,NIH stroke index, MMSE</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Brain Ischemia</condition>
  <arm_group>
    <arm_group_label>Propofol group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive the total intravenous anesthesia with propofol infusion during the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevo-C group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive the anesthesia with continuous inhalation of sevoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevo-I group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevoflurane will be given before the cerebral artery clip as a preconditioning procedure for the coming ischemia-reperfusion injury.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sev-I group</intervention_name>
    <description>Sevoflurane will be given before the cerebral artery clip as a preconditioning procedure for the coming ischemia-reperfusion injury.</description>
    <arm_group_label>Sevo-I group</arm_group_label>
    <other_name>Sevoflurane preconditioning</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sevo continuous inhalation</intervention_name>
    <description>Patients will receive the anesthesia with continuous inhalation of sevoflurane.</description>
    <arm_group_label>Sevo-C group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient under intracranial aneurysm surgery.

        Exclusion Criteria:

          -  Patients who refused to participate or who had a history of chemotherapy/convulsions
             two weeks prior to admission, stroke/cardiopulmonary resuscitation/head trauma three
             months prior to admission, Alzheimer's disease, amyotrophic lateral sclerosis, and
             prior melanoma were excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hailong Dong, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xijing Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lize Xiong, MD,PhD</last_name>
      <phone>86-2984775337</phone>
      <email>lxiong@fmmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2010</study_first_submitted>
  <study_first_submitted_qc>September 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2010</study_first_posted>
  <last_update_submitted>September 16, 2010</last_update_submitted>
  <last_update_submitted_qc>September 16, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Hailong Dong</name_title>
    <organization>Xijing Hospital, Fourth Military Medical University</organization>
  </responsible_party>
  <keyword>cerebral ischemia</keyword>
  <keyword>sevoflurane preconditioning</keyword>
  <keyword>intracranial aneurysm surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

